Search
for
Sort by
Research 391–420 of 1000+
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Different levels of EGF, VEGF, IL‐6, MCP‐1, MCP‐3, IP‐10, Eotaxin and MIP‐1α in the adipose‐derived stem cell secretome in androgenetic alopecia
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- [Purification of recombinant fusion polypeptide hEGF-AWRK6 and effect on wound healing and infection of burn model mice].
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Influences of IGF-1 and EGF on primary hair follicles of Liaoning cashmere goat in vitro.
- Ultrastructural Localization and Quantification of Extracellular Calcium Binding Sites in Mouse Vibrissa and Human Scalp Follicles
- Constructing EGF mRNA‐Enriched Extracellular Vesicles Based on the AAVS1 Safe Harbor Site to Promote Skin Wound Healing
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Effect of a Serenoa repens extract on human primary hair dermal papilla cells isolated from male and female donors
- MLPH-mediated activation of dermal papilla IGF-1 signaling drives human hair shaft elongation and anagen induction
- An autosomal recessive nonsense variant in the EGFR gene induces perinatal lethality in “Blonde d'Aquitaine” calves
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- In Vitro differentiation of hair-follicle bulge stem cells into synaptophysin-expressing neurons: a potential new approach for neuro-regeneration
- Unusual Dermatologic Findings in an Extremely Low Birthweight Infant: The Genetic Diagnosis
- Hypertrichosis Lanuginosa Acquisita: When Hair Unravels the Unseen
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis
- Data from Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- Data from Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Lady with Long Eyelashes…!
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Avaliação do efeito do ácido piperonílico na cicatrização de feridas em camundongos